Leprosy Mailing List – September 14, 2016
Ref.: (LML) International Leprosy Congress, Beijing, September 2016
From: Cairns Smith, Aberdeen, UK
Dear Colleagues,
I would like to refer to the message of Ben (LML, September 8, 2016) and suggest some topics for the discussion on “Clinical problems in leprosy”. As pointed out by Robert Jerskey (LML, September 8, 2016), this session will be held in room 201 CD, in the afternoon of September 19th (Monday), from 13.30-15.00 hours
Sample Questions to start the process:
1. How can I manage chronic, recurrent ENL when I do not have access to thalidomide?
2. 2. How long should I continue with steroid treatment for reversal reaction with nerve damage?
3. 3. Does histoid leprosy suggest drug resistance?
4. 4. Can you advise on treatment regimen for leprosy in a patient on anti-TB therapy?
5. 5. What are the indications for nerve decompression?
6. 6. When can we issue certificates of cure to MB and PB patients?
7. 7. How soon after starting MDT is the risk of transmission zero?
8. 8. Please advise on the treatment of leprosy and reactions in pregnancy – should MDT drugs be stopped?
9. 9. How can I differentiate pure neural leprosy from other peripheral neuropathies?
10. Is MRI and ultrasound of peripheral nerves in leprosy useful?
Cairns
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
 | Virusvrij. www.avast.com |
No comments:
Post a Comment